Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04678700
Other study ID # 20/139
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2021
Est. completion date August 1, 2021

Study information

Verified date December 2020
Source European University of Madrid
Contact Marta de la plaza, IP
Phone 0034659432984
Email marta_delaplaza@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this research project is to scientifically evidence a pulmonary rehabilitation program that was initiated altruistically during the confinement of those patients who had suffered from COVID-19, through an online platform. Patients are connected telematically 3 times a week from April 6, 2020 to perform the physical therapy program. Due to the clinical improvements that have been referred by patients, they began to take objective data. Our goal is to know if a telematic respiratory therapy program in post-covid 19 patient, improves the level of anxiety, dyspnea on effort, improves quality of life and oxygenation.


Description:

Patients affected by COVID- 19 have long periods of convalescence at home. This fact, together with the measures of social isolation, has contributed to act from a new therapeutic paradigm with the implementation of telematic rehabilitation programs. On April 6, 2020 the online platform was born under the name "Respiratory Physiotherapy; telematic assistance in patients with COVID-19 sequelae". We want to quantify the Chest Physiotherapy online program. Hypothesis; An online respiratory physiotherapy program offers improvements in quality of life, dyspnea and anxiety to patients who have suffered COVID-19. Objectives; General objective; To improve the pulmonary function of patients who have suffered from COVID-19 infection through an online respiratory physiotherapy program. Secondary objectives; - To improve the sensation of dyspnea; quantified by the Malher and Borg scale - To Normalize Breathing Rate - To Improve oxigenation; pulse-oximetry - To Improve the quality of life; quantified Euroqol- 5D - To Improve the feeling of anxiety; quantified by the STAI questionnaire METHODOLOGY/STUDY DESIGN; This is a program that was born under a very special need and circumstance, as is the coronavirus pandemic. The aim was to use respiratory tele-rehabilitation through an online platform with patients affected by coronavirus. The study is voluntary, the patient can stop the program at any time he or she considers appropriate. All of this is informed in the consent form that you give us, duly signed. I


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date August 1, 2021
Est. primary completion date June 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Patients in the recovery phase, hospitalised or at home. - Patients diagnosed with positive PCR for COVID-19 - Patient with sensation of dyspnea - Patient able to sit still Exclusion Criteria: - Patients admitted to intensive care and/or hemodynamically unstable - Patients connected to mechanical ventilation - Patients who do not have integrated cognitive abilities - Patients who are receiving other respiratory rehabilitation programs - Patients without adecuate technologies ( WIFI, computer, email, zoom)

Study Design


Intervention

Other:
Chest physiotherapy post-covid19
The sessions are divided into the following modules; Directed abdominal-diaphragmatic ventilation (10 times). Costal expansion exercises with the help of flexion and abduction of the upper limbs. (10 times)(1). Self-passive stretching of the ribcage and neck muscles, accessory to inspiration. The purpose of the stretching will be to increase the flexibility of the muscles to improve the vital capacity as has already been evidenced in other respiratory diseases such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis (25)(26). Relaxation time;Jacobson's progressive relaxation; we scan the body's condition. Post-session evaluation by taking the respiratory frequency/ min and the Borg's dyspnea index, and level oxigen after the exercises.

Locations

Country Name City State
Spain Marta de la plaza Madrid

Sponsors (1)

Lead Sponsor Collaborator
European University of Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Euroqol-5d european quality of life-5 dimensions The EQ-5D is a generic Quality of Life measurement instrument. The individual himself evaluates his state of health, first in levels of severity by dimensions. The descriptive system contains five health dimensions (mobility, self-care, activities of daily living, pain/discomfort and anxiety/depression) and each one has three levels of severity (no problems, some moderate problems or problems and serious problems). In this part of the questionnaire, the individual must mark the level of severity corresponding to his or her state of health in each one of the dimensions, referring to the same day that he or she completes the questionnaire. In each dimension of the EQ-5D, the levels of severity are coded with a 1 if the answer option is "no (I have) problems"; with a 2 if the answer option is "some or moderate problems"; and with a 3 if the answer option is "many problems". 1 week
Primary Euroqol-5d european quality of life-5 dimensions The EQ-5D is a generic Quality of Life measurement instrument. The individual himself evaluates his state of health, first in levels of severity by dimensions. The descriptive system contains five health dimensions (mobility, self-care, activities of daily living, pain/discomfort and anxiety/depression) and each one has three levels of severity (no problems, some moderate problems or problems and serious problems). In this part of the questionnaire, the individual must mark the level of severity corresponding to his or her state of health in each one of the dimensions, referring to the same day that he or she completes the questionnaire. In each dimension of the EQ-5D, the levels of severity are coded with a 1 if the answer option is "no (I have) problems"; with a 2 if the answer option is "some or moderate problems"; and with a 3 if the answer option is "many problems". 4 week
Primary Dysnea scale Borg The modified Borg scale is a visual analog scale standardized in Spanish that allows to evaluate the subjective perception of the breathing difficulty or the physical effort exercised.
This variable is taken in sedation
5 minutes before each session
Primary Dysnea scale Borg The modified Borg scale is a visual analog scale standardized in Spanish that allows to evaluate the subjective perception of the breathing difficulty or the physical effort exercised.
This variable is taken in sedation
5 minutes after each session
Primary Respiratory rate breathing rate in one minute. The patient sitting upright takes the number of breaths per minute. 5 minutes before each session
Primary Respiratory rate breathing rate in one minute. The patient sitting upright takes the number of breaths per minute. 5 minutes after each session
Primary Effort dysnea Scale Effort dyspnea scale, Malher Scale A multidimensional scale that measures 3 magnitudes of dyspnea at a given time: the difficulty of the task, the intensity of the effort and the functional impairment. 1 week
Primary Effort dysnea Scale Effort dyspnea scale, Malher Scale A multidimensional scale that measures 3 magnitudes of dyspnea at a given time: the difficulty of the task, the intensity of the effort and the functional impairment. 4 week
Primary Anxiety STAI, questionary of anxiety, we will take before the first session and at the end of the last session 1 week
Primary Anxiety STAI, questionary of anxiety, we will take before the first session and at the end of the last session 4 week
Primary Level oxigen % pulxe-oximetry, the patient is sitting at rest 1 week
Primary Level oxigen % pulxe-oximetry, the patient is sitting at rest 4 week